BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

BMEDvsBBHETF Comparison

ETF 1

BMED

iShares Health Innovation Active ETF

This fund is part of

Healthcare Technology

-0.16%

Full BMED fund page

VS

ETF 2

BBH

VanEck Biotech ETF

This fund is part of

US Health Care

-0.17%

Full BBH fund page

iShares Health Innovation Active ETF (BMED) belongs to the Healthcare Technology segment. VanEck Biotech ETF (BBH) is part of the US Health Care segment. BMED's top 3 sector exposures are Healthcare and Non-Corporate. In contrast, BBH's top sector exposures are Healthcare BMED is more expensive with a Total Expense Ratio (TER) of 0.77%, versus 0.35% for BBH. BMED is up 1.48% year-to-date (YTD) with +$4M in YTD flows. BBH performs better with 8.22% YTD performance, and -$7M in YTD flows. Run a side-by-side ETF comparison of BMED and BBH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

BMED vs BBH performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 07/17/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	BMED BBH	+7.90%+8.85%	+4.20%+5.63%	+1.48%+8.22%	+23.30%+30.28%	+23.27%+30.54%	+4.16%+4.30%
Flows	BMED BBH	--$63K	--$4M	+$4M-$7M	+$6M-$35M	+$4M-$180M	+$5M-$134M

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	BMED BBH	+17.48%+20.71%	+15.99%+19.67%	+16.00%+19.14%	+17.71%+21.54%
Max drawdown	BMED BBH	-7.61%-7.19%	-14.71%-10.54%	-19.76%-22.78%	-33.96%-39.88%
Max drawdown duration	BMED BBH	65d65d	176d150d	237d440d	1586d1803d

Trading data

Create an account to view trading data

Join for free

	BMED	BBH
Last sale 7/17/2026 at 1:30 PM	$30.65	$204.78
Previous close 07/16/2026	$30.80	$206.25
Consolidated volume 07/16/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of June 30, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

BMED

is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free

	BMED	BBH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 7/17/2026 at 1:30 PM

Live

Closed

	BMED	BBH
Last price	$30.65	$204.78
1D performance	-0.49%	-0.71%
AuM	$11.03 M	$398.53 M
E/R	0.77%	0.35%

Characteristics

	BMED	BBH
Management strategy	Active	Passive
Provider	iShares	VanEck
Benchmark	-	MVIS US Listed Biotech 25 Index
N° of holdings	51	24
Asset class	-	Equities
Trailing 12m distribution yield	Join	Join
Inception date	September 29, 2020	December 20, 2011
ESG	No	No

More BMED data on Trackinsight

More BBH data on Trackinsight

Exposure

Countries

BMED

USA

83.2%

Other

16.8%

BBH

USA

85.88%

Netherlands

7.11%

Other

7.01%

Sectors

BMED

Healthcare

94.88%

Other

5.12%

BBH

Healthcare

100%

Other

-0%

Diversification

BMED

Total weight of top 15 holdings out of 15

57.26%

BBH

Total weight of top 15 holdings out of 15

85.48%

Top 15 holdings

Data as of May 31, 2026

BMED

Gilead Sciences, Inc.

5.42%

Merck & Co., Inc.

5.17%

Johnson & Johnson

5.15%

Edwards Lifesciences Corp.

4.79%

BlackRock Cash Funds - Treasury

4.74%

Waters Corp.

3.84%

Biogen, Inc.

3.67%

Bruker Corp.

3.64%

Amgen, Inc.

3.41%

WuXi Biologics (Cayman), Inc.

3.13%

Charles River Laboratories International, Inc.

3.12%

Vertex Pharmaceuticals, Inc.

2.99%

Mettler-Toledo International, Inc.

2.80%

Danaher Corp.

2.77%

Moderna, Inc.

2.65%

BBH

Gilead Sciences, Inc.

14.30%

Amgen, Inc.

13.90%

Vertex Pharmaceuticals, Inc.

8.09%

argenx SE

6.06%

Regeneron Pharmaceuticals, Inc.

6.04%

IQVIA Holdings, Inc.

4.56%

Revolution Medicines, Inc.

4.55%

Natera, Inc.

4.26%

Biogen, Inc.

3.98%

Alnylam Pharmaceuticals, Inc.

3.79%

United Therapeutics Corp.

3.61%

Illumina, Inc.

3.21%

BeOne Medicines Ltd.

3.18%

Insmed, Inc.

3.04%

Moderna, Inc.

2.91%

Frequently asked questions about BMED and BBH

How have the BMED and BBH ETFs performed in 2026?

As of July 17, 2026, BMED is up 1.48% year-to-date (YTD), while BBH has returned 8.22%. That puts BBH better performer ahead so far this year.

Which ETF is attracting more investor money: BMED or BBH?

Year-to-date, the BMED ETF saw +$4M in flows, compared to -$7M for BBH.

Which ETF is more volatile: BMED or BBH?

Over the past year, BMED had a volatility of 15.99%, while BBH experienced 19.67%.

Which ETF is bigger: BMED or BBH?

As of July 17, 2026, BMED holds $11.03 M in assets under management (AUM), while BBH manages $398.53 M.

What sectors do the BMED and BBH ETFs invest in?

BMED leans toward sectors like Healthcare. Meanwhile, BBH focuses on Healthcare.

What are the top holdings of the BMED ETF and BBH ETF?

BMED top holdings include Gilead Sciences, Inc., Merck & Co., Inc. and Johnson & Johnson. BBH holds in its top three: Gilead Sciences, Inc., Amgen, Inc. and Vertex Pharmaceuticals, Inc..

BMEDvsBBHETF Comparison

iShares Health Innovation Active ETF

VanEck Biotech ETF

BMED vs BBH performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the BMED and BBH ETFs performed in 2026?

As of July 17, 2026, BMED is up 1.48% year-to-date (YTD), while BBH has returned 8.22%. That puts BBH better performer ahead so far this year.

Which ETF is attracting more investor money: BMED or BBH?

Year-to-date, the BMED ETF saw +$4M in flows, compared to -$7M for BBH.

Which ETF is more volatile: BMED or BBH?

Over the past year, BMED had a volatility of 15.99%, while BBH experienced 19.67%.

Which ETF is bigger: BMED or BBH?

As of July 17, 2026, BMED holds $11.03 M in assets under management (AUM), while BBH manages $398.53 M.

What sectors do the BMED and BBH ETFs invest in?

BMED leans toward sectors like Healthcare. Meanwhile, BBH focuses on Healthcare.

What are the top holdings of the BMED ETF and BBH ETF?

BMED top holdings include Gilead Sciences, Inc., Merck & Co., Inc. and Johnson & Johnson. BBH holds in its top three: Gilead Sciences, Inc., Amgen, Inc. and Vertex Pharmaceuticals, Inc..

Which ETF is more diversified: BMED or BBH?

BMED holds 54 securities with 57.26% of its assets in the top 15. BBH has 24 securities and a top 15 weight of 85.48%.

The ETF Industry Is Evolving Fast